NervGen Pharma Reports Third Quarter Financial Results and Provides Business Updates
Newsfileยท2025-11-24 12:05
NervGen Pharma Reports Third Quarter Financial Results and Provides Business UpdatesNovember 24, 2025 7:05 AM EST | Source: NervGen Pharma Corp.Expanded CONNECT SCI Study data demonstrated unprecedented durable improvement in function, independence, and quality of life in individuals living with chronic spinal cord injuryCompleted a U.S. Food and Drug Administration (FDA) Type C meeting in September; FDA confirmed that multiple regulatory routes are available to support approval of NVG-291 as ...